About Christopher Kiple
Christopher Kiple is a chief executive officer and director at Solius Labs.
Form D filings also name Christopher Kiple as a chair at Lungpacer.
Christopher Kiple first appears on SEC filings in 2022.
Experience
This experience comes from Christopher Kiple's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher Kiple in the role, so the role may have started earlier or lasted longer.
Solius Labs, Inc. Current
Chief Executive Officer and director
2023 – Present · Bainbridge Island, WA
Solius sells a light therapy device that stimulates vitamin D production in adults.
Lungpacer Medical, Inc. Current
Chair Of The Board Of Directors
2021 – Present · Exton, PA
Lungpacer makes a device to help ventilated hospital patients breathe independently.
VS
Ventec Life Systems
Chief Executive Officer
2015 – 2021
JM
J.P. Morgan
Banker
2013 – 2015
SL
Sidley Austin LLP
Associate - Attorney
2012 – 2013
HL
Husch Blackwell LLP
Government Affairs
2010 – 2012
GU
George Washington University
Associate Director of Development
2007 – 2012
CA
CHG and Associates
Lobbyist
2003 – 2006
Key Colleagues at Startups
The people Christopher Kiple works with at each company, as listed on that company's latest Form D.
Lungpacer Medical, Inc. · Form D, Oct 14, 2026
Douglas Evans
President and CEO, director
Joseph Kaufmann
Board Member
Bob Donohue
Board Member
Jan Pensaert
Board Member
JC
Jonathan Conlin
Secretary
Solius Labs, Inc. · Form D, May 14, 2026
RW
Rick White
Director
BP
Brett Parent
Director
SH
Scott Hirsch
Director
RW
Robert Wise
Chief Financial Officer
DG
David Good
Chief Special Projects Officer
CA
Christopher Ackerley
Director